COVID-19 中的机械循环支持。
Mechanical Circulatory Support in COVID-19.
机构信息
The Christ Hospital Heart and Vascular Institute, 2139 Auburn Avenue, Cincinnati OH 45219, USA.
The Christ Hospital Heart and Vascular Institute, 2139 Auburn Avenue, Cincinnati OH 45219, USA. Electronic address: https://twitter.com/wesyoungpa.
出版信息
Cardiol Clin. 2022 Aug;40(3):329-335. doi: 10.1016/j.ccl.2022.03.003. Epub 2022 Mar 25.
Abstract
Despite aggressive care, patients with cardiopulmonary failure and COVID-19 experience unacceptably high mortality rates. The use of mechanical circulatory support devices in this population offers potential benefits but confers significant morbidity and novel challenges for the clinician. Thoughtful application of this complex technology is of the utmost importance and should be done in a multidisciplinary fashion by teams familiar with mechanical support devices and aware of the particular challenges provided by this complex patient population.
摘要
尽管采取了积极的治疗措施，患有心肺衰竭和 COVID-19 的患者仍面临着不可接受的高死亡率。在这类人群中使用机械循环支持设备具有潜在的益处，但也会带来显著的发病率和新的临床挑战。因此，慎重应用这一复杂技术至关重要，应由熟悉机械支持设备且了解此类复杂患者群体特殊挑战的多学科团队以多学科的方式来实施。
相似文献
1
Mechanical Circulatory Support in COVID-19.
Cardiol Clin. 2022 Aug;40(3):329-335. doi: 10.1016/j.ccl.2022.03.003. Epub 2022 Mar 25.
2
Mechanical Circulatory Support in COVID-19.
Heart Fail Clin. 2023 Apr;19(2):205-211. doi: 10.1016/j.hfc.2022.08.003.
3
Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock.
Crit Care Med. 2017 Nov;45(11):1922-1929. doi: 10.1097/CCM.0000000000002676.
4
Cardiac extracorporeal life support: state of the art in 2007.
Cardiol Young. 2007 Sep;17 Suppl 2:104-15. doi: 10.1017/S1047951107001217.
5
[Mechanical circulatory support in cardiogenic shock].
Med Klin Intensivmed Notfmed. 2019 Feb;114(1):77-90. doi: 10.1007/s00063-018-0497-8. Epub 2018 Nov 6.
6
Overview of Options for Mechanical Circulatory Support.
Interv Cardiol Clin. 2021 Apr;10(2):147-156. doi: 10.1016/j.iccl.2020.12.009.
7
Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock.
Eur Heart J. 2020 Oct 7;41(38):3753-3761. doi: 10.1093/eurheartj/ehaa547.
8
Short-term mechanical circulatory support by veno-arterial extracorporeal membrane oxygenation in the management of cardiogenic shock and end-stage heart failure.
Expert Rev Cardiovasc Ther. 2014 Feb;12(2):145-53. doi: 10.1586/14779072.2014.880051. Epub 2014 Jan 13.
9
Mechanical Circulatory Support in Cardiogenic Shock due to Structural Heart Disease.
Interv Cardiol Clin. 2021 Apr;10(2):221-234. doi: 10.1016/j.iccl.2020.12.007. Epub 2021 Feb 15.
10
Acute Circulatory Collapse and Advanced Therapies in Patients with COVID-19 Infection.
Methodist Debakey Cardiovasc J. 2021 Dec 15;17(5):43-52. doi: 10.14797/mdcvj.1048. eCollection 2021.
引用本文的文献
1
Monitoring of the right ventricular responses to pressure overload: prognostic value and usefulness of echocardiography for clinical decision-making.
Cardiovasc Diagn Ther. 2024 Feb 15;14(1):193-222. doi: 10.21037/cdt-23-380. Epub 2024 Feb 1.
2
Interaction of COVID-19 With Common Cardiovascular Disorders.
Circ Res. 2023 May 12;132(10):1259-1271. doi: 10.1161/CIRCRESAHA.122.321952. Epub 2023 May 11.
3
Oxygen Therapy in Pulmonary Vascular Disease: A Systematic Review, Meta-Analysis, and Comment.
Heart Fail Clin. 2023 Jan;19(1S):e1-e11. doi: 10.1016/j.hfc.2022.11.001. Epub 2023 Feb 26.
本文引用的文献
1
Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation: A Natural Experiment.
Am J Respir Crit Care Med. 2022 Jun 1;205(11):1354-1357. doi: 10.1164/rccm.202110-2399LE.
2
Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications.
World J Clin Cases. 2022 Jan 21;10(3):762-776. doi: 10.12998/wjcc.v10.i3.762.
3
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.
Nat Med. 2022 Feb;28(2):410-422. doi: 10.1038/s41591-021-01630-0. Epub 2021 Dec 14.
4
Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.
Circ Heart Fail. 2021 Dec;14(12):e008477. doi: 10.1161/CIRCHEARTFAILURE.121.008477. Epub 2021 Nov 18.
5
Clinical outcomes of severe COVID-19 patients receiving early VV-ECMO and the impact of pre-ECMO ventilator use.
Int J Artif Organs. 2021 Nov;44(11):861-867. doi: 10.1177/03913988211047604. Epub 2021 Oct 7.
6
Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
Lancet. 2021 Oct 2;398(10307):1230-1238. doi: 10.1016/S0140-6736(21)01960-7. Epub 2021 Sep 29.
7
Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams.
J Am Coll Cardiol. 2021 Sep 28;78(13):1309-1317. doi: 10.1016/j.jacc.2021.07.044.
8
Increased Inpatient Mortality for Cardiovascular Patients During the First Wave of the COVID-19 Epidemic in New York.
J Am Heart Assoc. 2021 Aug 17;10(16):e020255. doi: 10.1161/JAHA.120.020255. Epub 2021 Aug 13.
9
Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.
Intensive Care Med. 2021 Aug;47(8):851-866. doi: 10.1007/s00134-021-06459-2. Epub 2021 Jul 7.
10
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry.
JAMA Cardiol. 2021 Sep 1;6(9):1078-1087. doi: 10.1001/jamacardio.2021.2065.
Zotero 插件